Property:Has Dose
V
0.03-0.04 units/min (fixed dose, do not titrate) +
N
0.03mg/kg IM/IV (max 1mg) +
H
Hypoplastic left heart syndrome#Prostaglandin E1 Maintain PDA patency, duct-dependent lesion Pediatric +
0.05-0.1mcg/kg/min IV +
T
Transposition of the great arteries#Prostaglandin E1 Maintain PDA patency, duct-dependent lesion Pediatric +
0.05-0.1mcg/kg/min IV +
0.05-0.1mcg/kg/min IV +
V
0.05-0.4mcg/kg/min (start 5-15mcg/min) +
R
A
0.1 mg/kg IV or 10 mg IM or 0.3 mg/kg PO; titrate 2-5 mg IV q5-10min +
P
0.1 mg/kg IV push (1st dose); 0.2 mg/kg IV push (2nd dose) +
O
0.1 mg/kg IV/IM/IO (max 2 mg); or 0.1 mg/kg IN via nasal atomizer +
D
0.1 units/kg/hr IV drip +
0.1 units/kg/hr IV infusion (no bolus); reduce to 0.02-0.05 units/kg/hr when BG <250 +
P
S
0.1-1 mcg/kg/min (typical start 5-20 mcg/min) +
H
0.1-1.6 mcg/kg/min +
P
A
0.15 mg/kg (min 2.5 mg) nebulized q20min x3, then 0.15-0.3 mg/kg q1-4h PRN; or continuous 0.5 mg/kg/hr +
E
0.15-0.3 mg/kg/hr IV drip +
C
0.15-0.6 mg/kg PO/IV/IM (max 10 mg) +
